What insurance policy changes affect code E05.01?

There are 2 tracked policy changes affecting code E05.01, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code E05.01?

Payers that have issued tracked updates for code E05.01 include: Aetna.

How do I get notified when code E05.01 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code E05.01. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code E05.01?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

E05.01 Insurance Policy Changes

ICD-10 E05.01 is officially defined as "Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm." code E05.01 is referenced in 2 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code E05.01 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Aetna · Identified Aug 15, 2026Medium impact
Graves' Ophthalmopathy Treatments (CPB 0419, reviewed 2026-04-23)
Aetna's Clinical Policy Bulletin 0419 covers treatments for Graves' ophthalmopathy (thyroid eye disease) under commercial medical plans. Aetna considers teprotumumab-trbw (Tepezza) medically necessary for adults 18 or older with moderate-to-severe active or inactive disease, for one course of 8 infusions, and considers repeat courses and all other indications experimental, investigational, or unproven. Orbital decompression, eye muscle surgery, eyelid surgery and orbital radiotherapy are medically necessary for severe disease only when conservative measures and medications have not been successful.
Aetna · Identified Aug 12, 2026Medium impact
Optical Coherence Tomography of the Head and Neck (CPB 0928, reviewed 2025-12-30)
Optical coherence tomography (OCT) of the head and neck is considered experimental, investigational or unproven for these uses because their effectiveness has not been established: annual OCT follow-up of thyroid ophthalmopathy after orbital decompression, dynamic OCT for actinic keratosis, endoscopic OCT for tympanoplasty, intra-operative wide-field OCT for deep margins in head and neck surgery, OCT for the middle ear, OCT for diagnosis of oral cancerous lesions, OCT for evaluation of voice disorders, OCT for monitoring radiation-induced skin changes in head and neck cancer, OCT angiography for detecting subclinical low perfusion in giant cell arteritis without manifest ocular involvement and in thyroid-associated ophthalmopathy, and OCT otoscopes for imaging the tympanic membrane and middle ear. CPT 0485T through 0486T, 92133 and 92134 are listed as not covered for the indications in this policy, and so are ICD-10 codes for head and neck cancer, thyroid eye disease, tympanic membrane and middle ear disorders, actinic keratosis, radiation-induced skin changes, giant cell arteritis, voice and resonance disorders, and oral cavity cancer screening.

Watch E05.01

Get one email when a payer policy names E05.01, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Graves' Ophthalmopathy Treatments (CPB 0419, reviewed 2026-04-23)

Optical Coherence Tomography of the Head and Neck (CPB 0928, reviewed 2025-12-30)

What insurance policy changes affect code E05.01?

Which payers have updated policy for code E05.01?

How do I get notified when code E05.01 policy changes?

Why do payers change policies for code E05.01?